Literature DB >> 24480733

Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease.

Milena N Stanković1, Dušan R Mladenović1, Ivana Duričić2, Slađana S Šobajić2, Jasmina Timić2, Bojan Jorgačević1, Vuk Aleksić1, Danijela B Vučević1, Rada Ješić-Vukićević3, Tatjana S Radosavljević4.   

Abstract

BACKGROUND AND AIMS: Methionine-choline deficient (MCD) diet duration necessary for development of non-alcoholic fatty liver disease (NAFLD) and the dynamic of lipid profile and fatty acids are not completely established. The study examined dynamics and association between liver free fatty acids (FFA), serum lipid profile and liver morphological changes on MCD diet-induced NAFLD in mice.
METHODS: Male C57BL/6 mice (n = 28) were divided into four groups (n = 7 per group): control: fed with standard chow, MCD diet-fed groups: 2, 4 or 6 weeks. After treatment, liver and blood samples were taken for histopathology, serum lipid profile, and liver FFA composition.
RESULTS: Hepatic FFA profile showed a decrease in saturated acids, arachidonic and docosahexaenoic acid, whereas proportions of docosapentaenoic, oleic and linoleic acid were increased. Total cholesterol, HDL and triglycerides progressively decreased, whereas LDL level progressively increased. Focal fatty change in the liver appeared after 2 weeks, whereas diffuse fatty change with severe inflammation and ballooned hepatocytes were evident after 6 weeks.
CONCLUSIONS: Six-week diet model may be appropriate for investigation of the role of lipotoxicity in the progression of NAFLD. Therefore, supplementation with n-3 polyunsaturated acid like DHA, rather than DPA, especially in the initial stage of fatty liver disease, may potentially have preventive effects and alleviate development of NAFLD/NASH and may also potentially reduce cardiovascular risk by moderating dyslipidemia.
Copyright © 2014 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Free fatty acids; Lipid status; Methionine-choline deficient diet; Mice; NAFLD

Mesh:

Substances:

Year:  2014        PMID: 24480733     DOI: 10.1016/j.arcmed.2013.12.010

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  17 in total

1.  Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.

Authors:  Hayley T Nicholls; Jason L Hornick; David E Cohen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-06       Impact factor: 4.052

2.  Chronic Leptin Deficiency Improves Tolerance of Physiological Damage and Host-Pathogen Cooperation during Yersinia pseudotuberculosis Infection.

Authors:  Karina K Sanchez; Katia Troha; Andre Mu; Samuel E Redford; Justin L McCarville; Arianna Insenga; Sarah Stengel; Yujung Michelle Lee; Janelle S Ayres
Journal:  Infect Immun       Date:  2022-08-04       Impact factor: 3.609

3.  MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis.

Authors:  Giuseppina Palladini; Laura Giuseppina Di Pasqua; Marta Cagna; Anna Cleta Croce; Stefano Perlini; Barbara Mannucci; Antonella Profumo; Andrea Ferrigno; Mariapia Vairetti
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

4.  Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression.

Authors:  Masashi Miyao; Hirokazu Kotani; Tokiko Ishida; Chihiro Kawai; Sho Manabe; Hitoshi Abiru; Keiji Tamaki
Journal:  Lab Invest       Date:  2015-07-27       Impact factor: 5.662

Review 5.  Metabolic regulation of tissue-resident memory CD8+ T cells.

Authors:  Trupti Vardam-Kaur; Jie Sun; Henrique Borges da Silva
Journal:  Curr Opin Pharmacol       Date:  2021-03-11       Impact factor: 5.547

6.  A portable single-sided magnetic-resonance sensor for the grading of liver steatosis and fibrosis.

Authors:  Ashvin Bashyam; Chris J Frangieh; Siavash Raigani; Jeremy Sogo; Roderick T Bronson; Korkut Uygun; Heidi Yeh; Dennis A Ausiello; Michael J Cima
Journal:  Nat Biomed Eng       Date:  2020-11-30       Impact factor: 25.671

7.  Prosteatotic and Protective Components in a Unique Model of Fatty Liver: Gut Microbiota and Suppressed Complement System.

Authors:  Long Liu; Xing Zhao; Qian Wang; Xiaoxian Sun; Lili Xia; Qianqian Wang; Biao Yang; Yihui Zhang; Sean Montgomery; He Meng; Tuoyu Geng; Daoqing Gong
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

8.  Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis.

Authors:  Águeda González-Rodríguez; M Pilar Valdecantos; Patricia Rada; Annalisa Addante; Inés Barahona; Esther Rey; Virginia Pardo; Laura Ruiz; Laura M Laiglesia; María J Moreno-Aliaga; Carmelo García-Monzón; Aránzazu Sánchez; Ángela M Valverde
Journal:  Mol Metab       Date:  2017-10-31       Impact factor: 7.422

9.  Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study.

Authors:  Juanwen Zhang; Ying Zhao; Chengfu Xu; Yani Hong; Huanle Lu; Jianping Wu; Yu Chen
Journal:  Sci Rep       Date:  2014-07-25       Impact factor: 4.379

Review 10.  Non-alcoholic fatty liver disease, diet and gut microbiota.

Authors:  Carmine Finelli; Giovanni Tarantino
Journal:  EXCLI J       Date:  2014-05-07       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.